Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AA, AAD, AbbVie, abrocitinib, accredited, acne, adagrasib, aesthetic, affinity, amplified, antitumor, assumption, auremolimab, autoreactive, Belgium, biotech, Broadly, CALR, calreticulin, CIBINQO, CMS, Cut, Cyclin, depigmenting, deplete, diagnostic, dissolution, domestic, Edmund, Erosion, erythema, escalation, ESG, excise, exempt, extremely, featured, forthcoming, geopolitical, Harrigan, hesitancy, highlighted, Hispanic, indirect, instability, introduced, kipping, lichen, lymphoid, mAb, macroeconomic, Maruho, mCALR, memory, Mirati, mucosal, multinational, mutant, NMPA, nonsegmental, notified, novo, obsolescence, oncoprotein, Orange, PBM, phototherapy, Plenary, portal, povorcitinib, purple, pyrexia, reimposed, repealed, replication, Republic, resident, retaliatory, RINVOQ, Russian, serine, Session, shrinkage, Southeast, Spain, speaking, steroid, Swissmedic, threonine, TRM, Ukraine, unfavorable, unfavorably, upadacitinib, urinary, usable, vivo, women, zilurgisertib
Removed:
AML, architectural, ASU, bankruptcy, bargaining, CMC, complementing, constructing, conversion, delivered, Dixon, eliminating, engineering, fedratinib, function, ground, half, indefinite, INREBIC, issuable, jointly, matching, matured, NaN, nominate, opt, pattern, Philadelphia, relief, removed, resourcing, Simplifying, topic, uncured, waiting, Wendy
Filing tables
Filing exhibits
Related press release
Associated INCY transcripts
INCY similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1)Registration Statement (Form S-3 No. 333-262591) of Incyte Corporation,
(2)Registration Statements (Form S-8 Nos. 333-31409, 333-174919, 333-212102 and 333-239162) pertaining to the 1997 Employee Stock Purchase Plan of Incyte Corporation, and
(3)Registration Statements (Form S-8 Nos. 333-167526, 333-174918, 333-182218, 333-189424, 333-197907, 333-212104, 333-225181, 333-231129 and 333-257041) pertaining to the Incyte Corporation Amended and Restated 2010 Stock Incentive Plan;
of our reports dated February 7, 2023, with respect to the consolidated financial statements of Incyte Corporation and the effectiveness of internal control over financial reporting of Incyte Corporation, included in this Annual Report (Form 10-K) of Incyte Corporation for the year ended December 31, 2022.
/s/ Ernst & Young LLP |
Philadelphia, Pennsylvania
February 7, 2023